ArticleCureus2025
Missed Follow-Up and Kaposi Sarcoma Progression: The Consequences of Medication Non-adherence.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Kaposi sarcoma (KS) is a serious AIDS-defining malignancy that can progress rapidly in the setting of profound immunosuppression. Non-adherence to antiretroviral therapy (ART) remains a major barrier to viral suppression, particularly among underserved populations. We present the case of a 36-year-old African American man who has sex with men (MSM), living in an underserved community, with a history of HIV/AIDS and late latent syphilis. The patient developed disseminated KS after six months of non-adherence to bictegravir/emtricitabine/tenofovir alafenamide (Biktarvy). He presented with a CD4 count of 44 cells/µL and a viral load of 592,000 copies/mL. Clinical findings included multiple violaceous skin lesions, pulmonary reticulonodular infiltrates with pleural effusion, and lymphadenopathy. Biopsy confirmed KS. He was restarted on ART and prophylactic antibiotics upon discharge. This case highlights the severe consequences of ART non-adherence in a vulnerable population. Targeted interventions, including long-acting ART, behavioral support, and telehealth innovations, are essential to improve retention in care and prevent advanced HIV-related complications like KS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.